News
T cell development is a tightly regulated process that transforms immature thymocytes into mature T cells with distinct functionalities. In the thymus, precursor cells undergo a series of selection ...
UCSF researchers designed a CAR T-cell therapy and combined it with an older class of diabetes drugs called ...
Using AlphaFold 3, an AI/ML model designed for protein structure prediction, the team demonstrated a novel approach to model ...
News-Medical.Net on MSN
A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development
CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.
The company has already been testing the autologous cell therapy, LioCyx-M004, in patients with certain liver cancers.
The Notch signaling pathway plays a pivotal role in determining cell fate, especially in the development and function of T cells. But mimicking this highly mechanical, contact-dependent pathway in the ...
Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 15, 2025 /EINPresswire.com/ -- What Is The Forecast For The T Cell Specific Surface Glycoprotein CD28 Market From 2024 To 2029? The market for the T ...
A new study uses AlphaFold 3 to predict T cell receptor interactions with peptide antigens, enabling faster discovery of ...
To address the challenge, Sino Biological has developed anti-whitlow 218 linker rabbit monoclonal antibodies, which specifically binds to the whitlow 218 linker sequence (GSTSGSGKPGSGEGSTKG). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results